Cardiff Oncology Inc (CRDF) — Cash Flow-to-Debt Ratio
Cardiff Oncology Inc (CRDF) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-5.97 Million could theoretically repay 0% of its total liabilities ($16.50 Million) in one year. See Cardiff Oncology Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cardiff Oncology Inc Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Cardiff Oncology Inc across 17 annual periods. Also explore how fast is Cardiff Oncology Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cardiff Oncology Inc (2009–2025)
Year-by-year debt coverage analysis for Cardiff Oncology Inc. For market capitalisation and broader financial context, see CRDF market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.30x | $-37.92 Million | $16.50 Million | ▲ +13.1% |
| 2024 | -2.65x | $-37.69 Million | $14.24 Million | ▼ -2.0% |
| 2023 | -2.60x | $-30.89 Million | $11.90 Million | ▲ +24.4% |
| 2022 | -3.43x | $-33.82 Million | $9.85 Million | ▼ -36.0% |
| 2021 | -2.52x | $-23.04 Million | $9.13 Million | ▼ -1.6% |
| 2020 | -2.48x | $-16.31 Million | $6.57 Million | ▼ -8.1% |
| 2019 | -2.30x | $-13.27 Million | $5.78 Million | ▲ +28.8% |
| 2018 | -3.23x | $-13.20 Million | $4.09 Million | ▲ +19.8% |
| 2017 | -4.03x | $-23.28 Million | $5.78 Million | ▼ -213.8% |
| 2016 | -1.28x | $-31.04 Million | $24.18 Million | ▼ -32.0% |
| 2015 | -0.97x | $-22.12 Million | $22.75 Million | ▼ -57.0% |
| 2014 | -0.62x | $-12.73 Million | $20.55 Million | ▲ +42.7% |
| 2013 | -1.08x | $-7.32 Million | $6.76 Million | ▼ -108.2% |
| 2012 | -0.52x | $-4.93 Million | $9.50 Million | ▼ -41.9% |
| 2011 | -0.37x | $-1.93 Million | $5.27 Million | ▲ +3.4% |
| 2010 | -0.38x | $-2.09 Million | $5.51 Million | ▼ -40.3% |
| 2009 | -0.27x | $-1.23 Million | $4.55 Million | — |